SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: (Original Filing)
[SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Form 6-K Page 3 4 2 SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED]
XNET [Xunlei] 6-K: XUNLEI LIMITED Sean Shenglong Zou Chief Executive Officer
[XUNLEI LIMITED Sean Shenglong Zou Chief Executive Officer No. Description Press Release XUNLEI ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER 2014 & ACCOUNCES PERSONAL STORAGE INITIATIVE Shenzhen, China, August 20, 2014 Xunlei Limited (Xunlei or the Company) (Nasdaq: XNET), Chinas leading provider of acceleration products and services, today announced its unaudited financial results for the quarter ended June]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Form 6-K Page
[SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Form 6-K Page 3 4 2 SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED]
CO [China Cord Blood] 6-K: (Original Filing)
[CHINA CORD BLOOD CORPORATION (incorporated in the Cayman Islands with limited liability) RULES OF THE RESTRICTED SHARE UNIT SCHEME Adopted by a resolution of the shareholders of China Cord Blood Corporation on February 18, 2011 and CONTENTS PAGE 1. Definitions and Interpretation 1 2. Purpose, Duration and Administration of this Scheme 3 3. Grant of Awards 4 4. Vesting 5] [FORM 6-K CHINA CORD BLOOD CORPORATION Hong Kong S.A.R. 48th Floor, Bank of China Tower Form 20-F x o o o Yes o x On August 21, 2014, the Board of Directors of China Cord Blood Corporation (the Company) amended certain administrative provisions of the 2011 China Cord Blood Corporation Restricted Share Unit Scheme. Description 4.9 2]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2 SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED]
CO [China Cord Blood] 6-K: CHINA CORD BLOOD CORPORATION (incorporated in the Cayman
[CHINA CORD BLOOD CORPORATION (incorporated in the Cayman Islands with limited liability) RULES OF THE RESTRICTED SHARE UNIT SCHEME Adopted by a resolution of the shareholders of China Cord Blood Corporation on February 18, 2011 and CONTENTS PAGE 1. Definitions and Interpretation 1 2. Purpose, Duration and Administration of this Scheme 3 3. Grant of Awards 4 4. Vesting 5] [FORM 6-K CHINA CORD BLOOD CORPORATION Hong Kong S.A.R. 48th Floor, Bank of China Tower Form 20-F x o o o Yes o x On August 21, 2014, the Board of Directors of China Cord Blood Corporation (the Company) amended certain administrative provisions of the 2011 China Cord Blood Corporation Restricted Share Unit Scheme. Description 4.9 2]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2 SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED]
ZX [China Zenix Auto International] 6-K: (Original Filing)
[China Zenix Auto International Announces Financial Results for the Second Quarter of 2014 ZHANGZHOU, China, August 21, 2014 China Zenix Auto International Limited Financial Highlights Second Quarter of 2014 Revenue of RMB959.7 million (US$154.7 million) compared with RMB1,059.3 million in the 2013 second quarter, and RMB896.1 million in the 2014 first quarter; Gross margin of 20.0%; ] [Form 6-K TABLE OF CONTENTS Page Explanatory Note Page 3 Page 4 Press Release Regarding Financial Results for the Second Quarter of 2014, dated August 21, 2014 Page 2 Please note that our financial statements are prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board and all references in the attached]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: (Original Filing)
[SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Form 6-K 3 4 2 SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED]
ZX [China Zenix Auto International] 6-K: China Zenix Auto International Announces Financial Results for
[China Zenix Auto International Announces Financial Results for the Second Quarter of 2014 ZHANGZHOU, China, August 21, 2014 China Zenix Auto International Limited Financial Highlights Second Quarter of 2014 Revenue of RMB959.7 million (US$154.7 million) compared with RMB1,059.3 million in the 2013 second quarter, and RMB896.1 million in the 2014 first quarter; Gross margin of 20.0%; ] [Form 6-K TABLE OF CONTENTS Page Explanatory Note Page 3 Page 4 Press Release Regarding Financial Results for the Second Quarter of 2014, dated August 21, 2014 Page 2 Please note that our financial statements are prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board and all references in the attached]
